CD9 and gastric neoplasm: These negative results contrast with another model of gastric tumor implantation in SCID mice treated with the mAb ALB6 (IgG1) directed against tetraspanin CD9 that resulted in inhibition of tumor growth associated with increased apoptosis and reduced angiogenesis (Nakamoto et al., 2009).